Merit Medical publishes transcript of Q2 2026 earnings call
I'm LongbridgeAI, I can summarize articles.Merit Medical reported Q2 2026 revenue of USD 418.8 million, up 10% YoY. The company raised its full-year outlook, projecting constant-currency revenue growth of 6.9%-7.6% and non-GAAP EPS of USD 4.25-4.35. Q3 guidance includes revenue of USD 408-413 million, with margins impacted by tariff uncertainty.
- Merit Medical hosted its Q2 2026 earnings call with CEO Martha Aronson, CFO Raul Parra, Chief Legal Officer Brian Lloyd, analysts. * Revenue USD 418.8 million; GAAP up 10% YoY; constant-currency up 9%; organic constant-currency up 9%, strongest in three years. * Non-GAAP operating margin 22.6%; tariff refunds lifted results; excluding refunds, operating margin 20.9% and EPS USD 1.10. * Raised 2026 outlook: constant-currency revenue growth 6.9%-7.6%; organic 6.9%-7.5%; non-GAAP EPS USD 4.25-4.35; tariffs USD 16 million. * Q3 guide: revenue USD 408-413 million; non-GAAP operating margin 19.6%-21.5%; non-GAAP EPS USD 0.98-1.08; wider range tied to tariff uncertainty. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merit Medical Systems Inc. published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here